Full Text View
Tabular View
No Study Results Posted
Related Studies
Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
This study has been completed.
Study NCT00972439   Information provided by USC/Norris Comprehensive Cancer Center

First Received on September 3, 2009.   Last Updated on September 4, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Oral Contraceptive
Interventions listed in this trial
Oral Contraceptive: Ovcon Fe®
Additional drug interventions recognized in this trial
Contraceptive Agents
Contraceptives, Oral
Ethynylestradiol mixture with norethindrone
Mestranol
Norethindrone
Norinyl
Progestins
More general drug interventions related to this trial
Contraceptive Agents, Female
Contraceptives, Oral, Combined
Contraceptives, Oral, Hormonal
Contraceptives, Oral, Sequential
Contraceptives, Oral, Synthetic
Estrogens
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
USC/Norris Comprehensive Cancer Center
Department of Defense


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services